| 1. |
Tamura T, Irie T, Deguchi S, Yajima H, Tsuda M, Nasser H, Mizuma K, Plianchaisuk A, Suzuki S, Uriu K, Begum MM, Shimizu R, Jonathan M, Suzuki R, Kondo T, Ito H, Kamiyama A, Yoshimatsu K, Shofa M, Hashimoto R, Anraku Y, Kimura KT, Kita S, Sasaki J, Sasaki-Tabata K, Maenaka K, Nao N, Wang L, Oda Y; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ikeda T, Saito A, Matsuno K, Ito J, Tanaka S, Sato K, Hashiguchi T, Takayama K, Fukuhara T., Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant., Nat Commun., 15, 1, 1176, 2024.02. |
| 2. |
Yamane D, Tetsukawa R, Zenmyo N, Tabata K, Yoshida Y, Matsunaga N, Shindo N, Ojida A., Expanding the Chemistry of Dihaloacetamides as Tunable Electrophiles for Reversible Covalent Targeting of Cysteines, J Med Chem., 66, 13, 9130-9146, 2023.07.  |
| 3. |
Tamura T, Ito J, Uriu K, Zahradnik J, Kida I, Anraku Y, Nasser H, Shofa M, Oda Y, Lytras S, Nao N, Itakura Y, Deguchi S, Suzuki R, Wang L, Begum MM, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Shimizu R, Tsuda M, Kosugi Y, Fujita S, Pan L, Sauter D, Yoshimatsu K, Suzuki S, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Schreiber G, Maenaka K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Hashiguchi T, Ikeda T, Fukuhara T, Saito A, Tanaka S, Matsuno K, Takayama K, Sato K., Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants., Nat Commun., 16, 14(1), 2800, 2023.05. |
| 4. |
Ito J, Suzuki R, Uriu K, Itakura Y, Zahradnik J, Kimura KT, Deguchi S, Wang L, Lytras S, Tamura T, Kida I, Nasser H, Shofa M, Begum MM, Tsuda M, Oda Y, Suzuki T, Sasaki J, Sasaki-Tabata K, Fujita S, Yoshimatsu K, Ito H, Nao N, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Kuramochi J, Schreiber G; Genotype to Phenotype Japan (G2P-Japan) Consortium; Saito A, Matsuno K, Takayama K, Hashiguchi T, Tanaka S, Fukuhara T, Ikeda T, Sato K., Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant., Nat Commun., 10.1038/s41467-023-38188-, 14, 1, 2671, 2023.05. |
| 5. |
Saito, Akatsuki; Tamura, Tomokazu; Zahradnik, Jiri; Deguchi, Sayaka; Tabata, Koshiro; Anraku, Yuki; Kimura, Izumi; Ito, Jumpei; Yamasoba, Daichi; Nasser, Hesham; Toyoda, Mako; Nagata, Kayoko; Uriu, Keiya; Kosugi, Yusuke; Fujita, Shigeru; Shofa, Maya; Begum, Mst Monira; Shimizu, Ryo; Oda, Yoshitaka; Suzuki, Rigel; Ito, Hayato; Nao, Naganori; Wang, Lei; Tsuda, Masumi; Yoshimatsu, Kumiko; Kuramochi, Jin; Kita, Shunsuke; Sasaki-Tabata, Kaori; Fukuhara, Hideo; Maenaka, Katsumi; Yamamoto, Yuki; Nagamoto, Tetsuharu; Asakura, Hiroyuki; Nagashima, Mami; Sadamasu, Kenji; Yoshimura, Kazuhisa; Ueno, Takamasa; Schreiber, Gideon; Takaori-Kondo, Akifumi; Shirakawa, Kotaro; Sawa, Hirofumi; Irie, Takashi; Hashiguchi, Takao; Takayama, Kazuo; Matsuno, Keita; Tanaka, Shinya; Ikeda, Terumasa; Fukuhara, Takasuke; Sato, Kei, Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant, CELL HOST & MICROBE, 10.1016/j.chom.2022.10.003, 30, 9, 1540, 2022.09. |
| 6. |
Izumi Kimura, Daichi Yamasoba, Tomokazu Tamura, Naganori Nao, Tateki Suzuki, Yoshitaka Oda, Shuya Mitoma, Jumpei Ito, Hesham Nasser, Jiri Zahradnik, Keiya Uriu, Shigeru Fujita, Yusuke Kosugi, Lei Wang, Masumi Tsuda, Mai Kishimoto, Hayato Ito, Rigel Suzuki, Ryo Shimizu, M.S.T. Monira Begum, Kumiko Yoshimatsu, Kanako Terakado Kimura, Jiei Sasaki, Kaori Sasaki-Tabata, Yuki Yamamoto, Tetsuharu Nagamoto, Jun Kanamune, Kouji Kobiyama, Hiroyuki Asakura, Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, Kotaro Shirakawa, Akifumi Takaori-Kondo, Jin Kuramochi, Gideon Schreiber, Ken J. Ishii, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Takao Hashiguchi, Terumasa Ikeda, Akatsuki Saito, Takasuke Fukuhara, Shinya Tanaka, Keita Matsuno, Kei Sato, Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants including BA.4 and BA.5, Cell, 10.1016/j.cell.2022.09.018, 185, 21, 3992-4007, 2022.10, After the global spread of the SARS-CoV-2 Omicron BA.2, some BA.2 subvariants, including BA.2.9.1, BA.2.11, BA.2.12.1, BA.4, and BA.5, emerged in multiple countries. Our statistical analysis showed that the effective reproduction numbers of these BA.2 subvariants are greater than that of the original BA.2. Neutralization experiments revealed that the immunity induced by BA.1/2 infections is less effective against BA.4/5. Cell culture experiments showed that BA.2.12.1 and BA.4/5 replicate more efficiently in human alveolar epithelial cells than BA.2, and particularly, BA.4/5 is more fusogenic than BA.2. We further provided the structure of the BA.4/5 spike receptor-binding domain that binds to human ACE2 and considered how the substitutions in the BA.4/5 spike play roles in ACE2 binding and immune evasion. Moreover, experiments using hamsters suggested that BA.4/5 is more pathogenic than BA.2. Our multiscale investigations suggest that the risk of BA.2 subvariants, particularly BA.4/5, to global health is greater than that of original BA.2.. |
| 7. |
Limsuwanchote S, Wungsintaweekul J, Yusakul G, Han JY, Sasaki-Tabata K, Tanaka H, Shoyama Y, Morimoto S, Preparation of a Monoclonal Antibody against Notoginsenoside R1, a Distinctive Saponin from Panax notoginseng, and Its Application to Indirect Competitive ELISA., Planta Med., 80, 4, 337-342, 2014.03. |
| 8. |
Chao Z, Tan M, Paudel MK, Sakamoto S, Ma L, Sasaki-Tabata K, Tanaka H, Shoyama Y, Xuan L, Morimoto S, Development of an indirect competitive enzyme-linked immunosorbent assay (icELISA) using highly specific monoclonal antibody against paclitaxel., J. Nat. Med., 67, 3, 512-518, 2013.07. |
| 9. |
Paudel MK, Shirota O, Sasaki-Tabata K, Tanaka H, Sekita S, Morimoto S, Development of an Enzyme Immunoassay Using a Monoclonal Antibody against the Psychoactive Diterpenoid Salvinorin A., J. Nat. Prod., 27, 76(9), 1654-1660, 2013.09. |
| 10. |
Mizuho Kajikawa, Kaori Sasaki-Tabata, Hideo Fukuhara, Masataka Horiuchi, Yuki Okabe, Katsumi Maenaka, Silkworm Baculovirus Expression System for Molecular Medicine, Journal of Biotechnology & Biomaterials, 2012.03. |
| 11. |
Paudel MK, Takei A, Sakoda J, Juengwatanatrakul T, Sasaki-Tabata K, Putalun W, Shoyama Y, Tanaka H, Morimoto S, Preparation of a single-chain variable fragment and a recombinant antigen-binding fragment against the anti-malarial drugs, artemisinin and artesunate, and their application in an ELISA., Anal Chem, 84, 4, 2002-2008, 2012.02. |
| 12. |
Sakamoto S, Pongkitwitoon B, Sasaki-Tabata K, Putalun W, Maenaka K, Tanaka H, Morimoto S., A fluorescent single domain antibody against plumbagin expressed in silkworm larvae for fluorescence-linked immunosorbent assay (FLISA)., Analyst., 136, 10, 2056-63, 2011.05. |
| 13. |
Hirunuma M, Shoyama Y, Sasaki K, Sakamoto S, Taura F, Shoyama Y, Tanaka H, Morimoto S., Flavone-catalyzed apoptosis in Scutellaria baicalensis., Phytochemistry., 72, 8, 752-60, 2011.06. |
| 14. |
Sakamoto S, Pongkitwitoon B, Nakamura S, Sasaki-Tabata K, Tanizaki Y, Maenaka K, Tanaka H, Morimoto S., Construction, Expression, and Characterization of a Single-Chain Variable Fragment Antibody Against 2,4-Dichlorophenoxyacetic Acid in the Hemolymph of Silkworm Larvae., Appl Biochem Biotechnol., 2011.01. |
| 15. |
Sasaki K, Taura F, Shoyama Y, Morimoto S, Molecular characterization of a novel beta-glucuronidase from Scutellaria baicalensis georgi, J. Biol. Chem., 275, 35, 27466-27472, 2000.09. |
| 16. |
Tanaka T, Mizukoshi T, Sasaki K, Kohda D, Masai H, Escherichia coli PriA protein, two modes of DNA binding and activation of ATP hydrolysis, J. Biol. Chem., 282, 27, 19917-19927 , 2007.07. |
| 17. |
Morimoto S, Tanaka Y, Sasaki K, Tanaka H, Fukamizu T, Shoyama Y, Shoyama Y, Taura F, Identification and characterization of cannabinoids that induce cell death through mitochondrial permeability transition in Cannabis leaf cells, J. Biol. Chem., 282, 28, 20739-20751 , 2007.07. |
| 18. |
Nakamura S, Kuroki K, Ohki I, Sasaki K, Kajikawa M, Maruyama T, Ito M, Kameda Y, Ikura M, Yamamoto K, Matsumoto N, Maenaka K, Molecular basis for E-cadherin recognition by killer cell lectin-like receptor G1 (KLRG1), J. Biol. Chem., 284, 40, 27327-27335 , 2009.10. |
| 19. |
Sasaki K, Ose T, Tanaka T, Mizukoshi T, Ishigaki T, Maenaka K, Masai H, Kohda D, Crystallization and preliminary crystallographic analysis of the N-terminal domain of PriA from Escherichia coli, Biochim. Biophys. Acta, 1764, 1, 157-160 , 2006.01. |
| 20. |
Sasaki K, Ose T, Okamoto N, Maenaka K, Tanaka T, Masai H, Saito M, Shirai T, Kohda D, Structural basis of the 3'-end recognition of a leading strand in stalled replication forks by PriA, EMBO J., 26, 10, 2584-2593 , 2007.05. |
| 21. |
Hashiguchi T, Kajikawa M, Maita N, Takeda M, Kuroki K, Sasaki K, Kohda D, Yanagi Y, Maenaka K, Crystal structure of measles virus hemagglutinin provides insight into effective vaccines, Proc. Natl. Acad. Sci. U S A, 104, 49, 19535-19540 , 2007.12. |
| 22. |
Hashiguchi T, Kajikawa M, Maita N, Takeda M, Kuroki K, Sasaki K, Kohda D, Yanagi Y, Maenaka K, Homogeneous sugar modification improves crystallization of measles virus hemagglutinin, J. Virol. Methods, 149, 1, 171-174 , 2008.04. |
| 23. |
Sasaki K, Kajikawa M, Kuroki K, Motohashi T, Shimojima T, Park EY, Kondo S, Yagi H, Kato K, Maenaka K, Silkworm expression and sugar profiling of human immune cell surface receptor, KIR2DL1, Biochem. Biophys. Res. Commun., 387, 3, 575-580 , 2009.09. |
| 24. |
Ono K, Fuma K, Tabata K, Sawada M, Ferritin reporter used for gene expression imaging by magnetic resonance, Biochem. Biophys. Res. Commun., 388, 589-594 , 2009.10. |
| 25. |
Kajikawa M, Sasaki K, Wakimoto Y, Toyooka M, Motohashi T, Shimojima T, Takeda S, Park EY, Maenaka K, Efficient silkworm expression of human GPCR (nociceptin receptor) by a Bombyx mori Bacmid DNA system, Biochem. Biophys. Res. Commun, 385, 3, 375-379 , 2009.07. |
